Afin de caractériser les profils de distribution de l’ARN Pol II en aval des EAGs, j’ai réalisé des expériences de ChIP-seq en utilisant un anticorps reconnaissant toutes les formes d’ARN Pol II humaine. J’ai analysé les profils de Pol II en aval de 13787 gènes qui n’ont pas de gène flanquant à +/- 4kb en amont ou en aval. Nos résultats ont été analysés en comparaison avec des données disponibles de séquençage à haut débit d’ARN naissants (Global Run On assay coupled sequencing : GRO-seq). Nos résultats montrent qu’un enrichissement de la Pol II en aval de l’extrémité des unités de transcription est une caractéristique partagée par tous les gènes exprimés et reflète la présence d’ARN Pol II active. Des analyses bioinformatiques (K-means clustering) m’ont permis de distinguer quatre groupes de gènes : le premier groupe (H) est caractérisé par un profil de pause étroit alors que les trois autres groupes (PA1-PA3) montrent un profil large ou très large, pouvant aller jusqu’à 6kb en aval des EAGs. Des analyses d’annotations (Gene Ontology) révèlent que le groupe H contient pratiquement exclusivement des gènes d’histones qui ne contiennent pas d’intron et dont les transcrits ne sont pas polyadénylés. A l’inverse, les groupes PA1-PA3 contiennent des gènes codant pour des transcrits polyadénylés. J’ai confirmé par des expériences de ChIP couplées à une analyse par qPCR les différents types de profils de distribution de Pol II décrits par analyse bioinformatique. Nos résultats sont en accord avec d’autres publications et suggèrent un lien entre le profil de distribution de la Pol II à l’extrémité 3’ des gènes histones et les mécanismes particuliers de maturation de l’extrémité 3’ de ces transcrits. Cette idée est renforcée par nos analyses fonctionnelles montrant que l’inhibition des mécanismes de polyadénylation augment la présence de l’ARN Pol II en 3’ des EAGs pour les gènes codant pour des transcrits polyadénylés. / The Pol II transcription cycle can be divided into three main phases: transcription initiation, elongation and termination. Each phase represent a possibility for the regulation of gene expression. Recently, genome-wide studies demonstrated that Pol II pausing is an important regulatory step that is present at almost every eukaryotic Pol II promoter. Surprisingly, paused or slowed down polymerases were also discovered downstream of 3’ end of genes, of which the exact role is still not fully understood.During my Ph.D. I carried out projects using chromatin immunoprecipitation assay coupled to high-throughput sequencing techniques to analyze genome-wide Pol II behavior in two aspects:First, we analyzed Pol II occupancy downstream of 3’ end of transcription units. Our analyses suggest that accumulation of Pol II downstream of genes is a genome-wide feature of active transcription. We found broad, often up to 6kb long Pol II occupancy signals at genes coding for polyadenylated transcripts. In contrast, Pol II occupancy shows a narrow profile at the annotated end of core histone genes. We also found a link between RNA 3’ end processing and Pol II accumulation at the end of transcription units.Second, we were following the genome-wide response and alteration of Pol II transcription upon genotoxic stress. Following UV-B treatment we observed a progressive Pol II signal loss from the promoters of expressed genes, which will then extend through the entire transcription unit, up to four hours after irradiation. This is in good agreement with the observation that after UV irradiation transcription is arrested during the period of transcription-coupled repair (TCR).

Recentemente, tem sido demonstrado que a maioria dos RNAs transcritos em células humanas são RNAs não-codificadores de proteínas (ncRNAs) originados de íntrons ou regiões intergênicas. Em trabalhos anteriores realizados por nosso grupo, foram descritos longos ncRNAs transcritos de regiões intrônicas de genes codificadores e cuja expressão foi correlacionada ao grau de diferenciação de tumores de próstata, apontando para a relevância fisiológica desta classe de transcritos. Apesar de sua abundância, as propriedades, funções e regulação da grande maioria dos ncRNAs ainda não foram elucidadas. O objetivo do presente trabalho foi investigar a biossíntese de ncRNAs intrônicos em células humanas, primordialmente a contribuição da RNA Polimerase II (RNAP II), bem como aspectos de sua regulação. Primeiramente, o modelo de regulação da expressão gênica por hormônio andrógeno foi utilizado para avaliação da participação direta de um fator de transcrição de RNAP II, o Receptor de Andrógeno (AR), na modulação da transcrição de ncRNAs intrônicos. Utilizando-se a técnica de imunoprecipitação da cromatina, foi detectada a ligação do AR ao elemento de resposta a andrógeno (ARE) presente em um possível promotor de um transcrito intrônico antisenso (derivado do locus Myo5A), cuja expressão é aumentada em células da linhagem LNCaP tratadas com o hormônio. A ligação ao ARE foi induzida pelo tratamento, sugerindo que o efeito do andrógeno na expressão do ncRNA é mediado pelo AR. Em uma segunda abordagem, o efeito da inibição da transcrição por RNAP II com α-amanitina por 24 h em células LNCaP foi avaliado com o uso de microarranjos de oligonucleotídeos representando transcritos total ou parcialmente intrônicos, além de éxons de genes codificadores. A expressão de menos de 20 % dos transcritos intrônicos foi afetada, fração significativamente menor que a observada para os transcritos exônicos (40 %). Ainda que a maioria dos ncRNAs intrônicos diferencialmente expressos tenha sua abundância diminuída, interessantemente, 13 a 16 % foram aumentados, contrastando com aproximadamente 2 a 3 % de exônicos que aumentaram. Os resultados obtidos neste trabalho indicam que a RNAP II atua na transcrição de ncRNAs intrônicos, mas que uma fração considerável pode ser transcrita por outra RNA Polimerase. / It has been recently shown that the bulk of the transcription in human cells is comprised of non-protein-coding RNAs (or noncoding RNAs - ncRNAs) transcribed from introns and intergenic regions of the genome. Previous work from our group has demonstrated that expression of long intronic ncRNAs can be correlated to the degree of prostate tumor differentiation, underscoring the physiological relevance of these transcripts. However, the properties, functions, and regulation of this huge population of ncRNAs remain largely unknown. The present work aimed to investigate the biosynthesis of intronic ncRNAs and aspects of its regulation in human cells, focusing on the contribution of RNA Polymerase II (RNAP II). Initially, the model of regulation of gene expression by androgen hormone was used in order to evaluate the participation of the RNAP II transcription factor Androgen Receptor (AR) in the transcriptional regulation of intronic ncRNAs. Chromatin immunoprecipitation experiments revealed the binding of the AR in an androgen response element (ARE) present in a putative promoter driving the expression of an antisense intronic transcript in Myo5A locus in LNCaP cells. The interaction occurred in an androgen-inducible fashion, along with the up-regulation of the transcript, suggesting that hormone activation occurred in a direct manner mediated by the AR. In a different approach, the effect of RNAP II inhibition with α-amanitin for 24 h in LNCaP cells was analyzed using an oligoarray representing totally and partially intronic transcripts, as well as exons of proteincoding genes. The expression of less than 20 % of the intronic transcripts was affected by the treatment, contrasting to a significantly higher fraction observed for exonic messages (40 %). Moreover, most differentially expressed intronic transcripts were down-regulated, but strikingly 13 to 16 % were up-regulated in cells with blocked RNAP II, while this fraction for exonic transcripts was about 2 %. The results described here demonstrate that RNAP II in fact plays a role in intronic transcription in human cells, but also highlight that another transcriptional system may account for the biogenesis of a fraction of intronic ncRNAs.

Les complexes acétyltransférases (HAT), SAGA et ATAC, sont des régulateurs de la transcription des gènes. Cependant, peu d’études ont été menées sur la dynamique de ces complexes au niveau cellulaire et sur les mécanismes régulant leur assemblage. Au cours de mes travaux de thèse, j’ai utilisé des approches d’imagerie sur cellules vivantes, afin de déterminer la mobilité de ces complexes en comparaison avec celle d’autres régulateurs transcriptionnels. Les résultats ont montré que les sous-unités de SAGA et ATAC interagissent de manière transiente avec la chromatine. En complément, nous avons montré que les sous-unités spécifiques de SAGA et ATAC (ADA2b et ADA2a) ont des propriétés dynamique intracellulaire différentes et que GCN5, affecte la distribution d’ADA2a. Des analyses protéomique menées sur le comportement de ces protéines au niveau endogène, ont permis de montrer que les voies d’assemblage de ces deux complexes étaient différentes au niveau cytoplasmique et nucléaire. / Human SAGA and ATAC, are histone acetyltransferase (HAT) containing complexes that share a set of subunits and facilitate RNA polymerase II (Pol II) transcription. Little is known for the dynamics of the complexes in living cells and the regulation of their assembly. In this work, we used live-cell imaging to characterise the mobility of the two complexes and compare it with other actors of Pol II transcription. All tested ATAC and SAGA subunits exhibit very transient interactions with chromatin, a property that explains certain aspects of the function of the complexes. Moreover, we showed that overexpressed ATAC- and SAGA-specific HAT-module subunits (ADA2a and ADA2b respectively) have different intracellular dynamics and that the abundance of the shared subunit GCN5, affects the distribution of ADA2a. Quantitative proteomic analysis expanded our findings on endogenous proteins and provided evidence that the cytoplasmic and nuclear assembly pathways of SAGA and ATAC are different.

Abstract During DNA replication cells accurately copy their DNA to transfer the genetic information to daughter cells. DNA polymerases synthesise the new DNA strand using the old strand as a template. Other functions of DNA polymerases are recombination linked and DNA iamage repair linked DNA synthesis, regulation of replication complex formation and regulation of transcription – a process in which the genetic information is transformed into an RNA sequence needed to guide protein synthesis. In this study, the TopBP1 protein was shown to associate with DNA polymerase epsilon. TopBP1 contains eight BRCT domains mediating interactions between phosphorylated proteins and is a human homolog of bakers yeast Dpb11 and fission yeast Cut5. These yeast proteins act on DNA replication and cell cycle arrest after DNA damage. TopBP1 was found to be phosphorylated and expressed in elevated amounts during S phase suggesting an involvement in DNA replication. This was directly demonstrated by DNA synthesis inhibition by a competing TopBP1 fragment and by an antibody targeted to block TopBP1. Ultraviolet irradiation damages DNA and decreases the amount of TopBP1 in the nucleus. The transcription factor Miz-1 was found to associate with TopBP1 and was released from this interaction after UV damage. Free Miz-1 activated the expression of the cell cycle arresting proteins p15 and p21 cooperatively with other transcription factors and allowed extra time for DNA damage repair. TopBP1 was also found to interact with the breast cancer susceptibility protein 1 and both proteins localised together to arrested DNA synthesis apparatuses. The interaction of TopBP1 with the damage recognition and processing protein Rad9 is still further evidence of a link between TopBP1 and DNA damage. DNA polymerase epsilon forms a complex with Cdc45, a protein involved in DNA replication initiation and elongation. This complex does not interact with Cdc45 complexed with DNA polymerase delta, suggesting that these complexes synthesise DNA independently of each other. Our results are in agreement with the view that polymerase epsilon synthesises the first strand of DNA and polymerase delta the other. Finally,DNA polymerase epsilon binds to the RNA synthesising form of RNA polymerase II and nascent transcripts. The physiological meaning of this interaction needs to be determined.

RNA polymerase II (Pol II) is the enzyme responsible for the synthesis of all mRNAs in eukaryotic cells. As the central component of the eukaryotic transcription machinery, Pol II is the final target of transcription regulatory pathways. While the role for different Pol II associated proteins, co-activators and general transcription factors (GTFs) in regulation of transcription in response to different stimuli is well studied, a similar role for some subunits of the core Pol II is only now being recognized. The studies reported in this thesis address the role of the fourth largest subunit of Pol II, Rpb4, in transcription and stress response using Saccharomyces cerevisiae as the model system. Rpb4 is closely associated with another smaller subunit, Rpb7 and forms a dissociable complex (Edwards et al. 1991). The rpb4 null mutant is viable but is unable to survive at extreme temperatures (>34ºC and <12ºC) (Woychik and Young, 1989). This mutant has also been shown to be defective in activated transcription and unable to respond adequately to several stress conditions (Pillai et al. 2001; Sampath and Sadhale, 2005). In spite of wealth of available information, the exact role of Rpb4 in transcription process remains poorly understood. In the present work, we have used genetic, molecular and biochemical approaches to understand the role of Rpb4 as described in three different parts below: I. Role of Rpb4 in various pathways related to Transcription Elongation The genome-wide recruitment study of RNA pol II in presence and absence of Rpb4 has indicated role of Rpb4 in transcription elongation (Verma-Gaur et al. 2008). However, a recent proteomics based report has argued against it (Mosley et al. 2013). To address this conflict and understand Rpb4 functions, we monitored recruitment of RNA pol II on a few individual long genes in wild type and rpb4∆ cells. It was observed that RNA pol II recruitment on genes with longer coding regions is not significantly affected in rpb4∆ as compared to wild type thus ruling out role of Rpb4 in transcription elongation of these genes. However, our genetic interaction studies have shown a strong interaction (synthetic lethality) between RPB4 and the PAF1 and SPT4 genes, the products of which code for well-known transcription elongation factors. The studies based on Rpb4 overexpression in mutants for elongation factors, 6-Azauracil sensitivity of cells, effect of Dst1 overexpression in rpb4∆ cells and mitotic recombination rate in rpb4∆ cells have indicated functional interactions of Rpb4 with many of the transcription elongation factors. II. Studies on Genetic and Functional Interactions of Rpb4 with SAGA Complex in Promoter- Specific Transcription Initiation To carry out transcription, RNA pol II depends on several general transcription factors, mediators, activators, co-activators and chromatin remodeling complexes. In the present study, we explored the genetic and functional relationships between Rpb4 and the SAGA complex of transcription machinery, to gain some insight on the role of Rpb4 during transcription. Our chromatin immunoprecipitation data suggest that RNA pol II does not associate with promoters of heat shock genes during transcription activation of these heat stress induced genes in absence of Rpb4. SAGA coactivator complex is required for RNA pol II recruitment and transcription activation of these genes (Zanton and Pugh, 2004). However, recruitment of the SAGA complex at promoters of these heat shock genes was not affected in rpb4∆ cells after heat stress. Our genetic interaction analysis between RPB4 and components of SAGA complex (spt20∆) showed synthetic lethality indicating that fully functional Rpb4 and SAGA complex are required for cellular functions in the absence of heat stress and the simultaneous deletion of factors in the two complexes leads to cell death. III. Role of Rpb4 in phosphorylation cycles of Rpb1-CTD The C-Terminal Domain (CTD) of Rpb1 protein of RNA pol II undergoes several rounds of phosphorylation cycles at Ser-2 and Ser-5 residues on its heptad repeats during transcription. These phosphorylation marks are to be erased before the start of next round of transcription. Using protein pull down assay, we observed that hyperphosphorylated form of Rpb1 is reduced in rpb4∆ as compared to that seen in wild type cells among the free RNA pol II molecules. The level of Rpb2 protein was unaffected in both wild type and rpb4∆. These preliminary data hints at role of Rpb4 in the regulation of Rpb1 phosphorylation.

Le processus transcriptionnel par l'ARN polymérase II (Pol II) chez les eucaryotes se déroule en trois étapes : L'initiation, l'élongation et la terminaison. De nombreux facteurs de transcription, des modifications de la chromatine (épigénétique) et des éléments régulateurs distants interviennent dans ce processus. La sous-unité RPB1 de l'ARN Pol II contient un domaine carboxyle terminale (CTD) composée d'une répétition de sept acides-aminés. Au travers de différentes modifications biochimiques, ce domaine coordonne le processus transcriptionnel par le recrutement de différents facteurs. Le CTD est également impliqué dans la coordination de la transcription au niveau de l'initiation, de l'élongation et de la terminaison par le biais de modifications épigénétiques et nucléosomales, mais aussi par l'action de régulateurs distants (enhancers) et probablement de changements de conformation tridimensionnelle du génome. Mon travail de thèse a consisté en l'étude de deux modifications biochimiques du CTD de l'ARN Pol II par traitement bioinformatique de données issues du séquençage haut-débit. J'ai pu montrer que la phosphorylation de la thréonine 4 influence l'élongation de la transcription chez l'humain. J'ai également montré que la phosphorylation de la tyrosine 1 est présente durant l'initiation, est préférentiellement localisée dans la direction anti-sens, est hyper-phosphorylée aux enhancers transcrits et tissus spécifiques et est une marque caractéristique de ces modules génomiques. Ce travail de doctorat a constitué une contribution à la compréhension du processus transcriptionnel chez l'humain par l'utilisation de méthodes bioinformatiques innovantes. / The biggest subunit of eukaryotic RNA polymerase II contains a carboxy-terminal domain (CTD) that consists in a repetition of seven amino-acids ranging from 26 in yeast to 52 in mammals. Specific biochemical modifications of CTD residues have been linked to specific stages of the transcriptional process. The CTD acts as a recruitment platform for processing factors that are involved in initiation, promoter proximal pausing, early and productive elongation (alternative splicing), 3' processing, termination and epigenetics.During my PhD, I used bioinformatics and high-throughput sequencing data to study two novel biochemical modifications of the CTD in human. I showed, in collaboration with biologists and bioinformaticians, that threonine 4 phosphorylation is important for proper elongation and probably termination of transcription. I showed also that tyrosine 1 phosphorylation is present during early transcription, antisense transcription (at divergent promoters) and is hyperphosphorylated at transcribed and tissue specific enhancers.Overall my doctorate has contributed to the understanding of the transcriptional process in human through the use of innovative bioinformatic methods.

Les mécanismes de régulation de l’expression génétique sont essentiels pour l’adaptation du comportement cellulaire face à son environnement (différenciation, développement, réponse à un stimulus). Les études moléculaires décrivent une grande diversité de facteurs impliqués dans ce phénomène (TFs, marques épigénétiques, nucléosomes) et plusieurs niveaux de régulation (initiation, élongation, épissage, maturation) qui expliquent la complexité du transcriptome cellulaire. Durant ma thèse, nous nous sommes intéressés aux processus de régulation de la transcription en nous appuyant sur le modèle de la différenciation lymphocytaire murine. Nos études décrivent le recrutement des GTFs et une activité transcriptionnelle caractéristique aux promoteurs des gènes et sur les enhancers. Nous montrons également que les ilots CpG (CGIs) sont des éléments régulateurs majeurs chez les mammifères et qu’ils contribuent de manière transcription-indépendante à la déplétion nucléosomale observée aux promoteurs de certains gènes. Nos collaborations nous ont également permis d’aborder des sujets relatifs à l’élongation de la transcription, l’épissage alternatif, ou les combinatoires de PTMs que peuvent exhiber le CTD de l’ARN Pol II et les queues d’histones. Dans un contexte de transition de l’ère pré-génomique vers des approches expérimentales pangénomiques (s’appuyant notamment sur les technologies de séquençage haut débit), une proportion importante de ma période doctorale fut consacrée au développement d’outils bioinformatiques pour le traitement et les analyses de données expérimentales, issues de ChIP-on-chip puis de HTS (ChIP-Seq, MNase-Seq, RNA-Seq). / Mechanisms underlying the regulation of genetic expression are crucial for cell maintenance and adaptation to environment (differentiation, development...). Molecular approaches reveal a great diversity of factors involved in this process (TFs, epigenetics, nucleosomes) and several layers of regulation (transcription initiation, elongation, splicing, maturation) which contribute to the observed transcriptome complexity. During my thesis, we studied the mechanisms of transcription regulation in mammals during lymphocyte differentiation. Briefly, we described the recruitment of GTFs and the transcriptional activity occurring on promoters and enhancers. We also reveal that CpG islands (CGIs) are major regulator elements in mammals, which contribute to nucleosome depletion in a transcription-independent manner on a significant amount of promoters. Together with our collaborators, we also studied the mechanisms of transcription elongation, alternative splicing, or the complex combinatorial patterns of PTMs that can be set on the CTD of RNA Polymerase II and on histone tails. In the context of transition from pre-genomic studies to genome-wide experiments, an important part of my work consisted in the development of bioinformatics tools for the processing and analysis of experimental datasets from ChIP-on-chip, and HTS technologies (ChIP-Seq, MNase-Seq, RNA-Seq).

Transcription by RNA polymerase II is a highly regulated process requiring a number of general and promoter specific transcription factors. Although many of the factors involved in the transcription reaction are known, exactly how they function to stimulate or repress transcription is not well understood. Central to understanding gene regulation is understanding the mechanism by which promoter specific transcription activators (activators) stimulate transcription. A group of factors called coactivators have been shown to be required for activator function in vitro. The best characterized coactivators to date are members of the TFIID complex. TFIID is a multisubunit complex composed of the TATA box binding protein (TBP) and 8-12 TBP associated factors (TAFIIs). Results from numerous in vitro experiments indicate that TAFIIs function by binding to activators and forming a bridge between the activator and the basal transcription machinery. In order to gain insight into the mechanism by which activators stimulate transcription, we chose to analyze the in vivo function of TAFIIs, their proposed targets. Results from the genetic disruption of a number of TAFIIs in the yeast Saccharomyces cerevisiae showed that most are encoded by essential genes. In order to study their function, temperature-sensitive and conditional alleles were constructed. Cells depleted of individual TAFIIs by either of these two methods displayed no defect in global transcription activation. Inactivation of yTAFII17, however, resulted in a promoter specific defect. In addition, inactivation of yTAFII145, yTAFII90, or TSM1, resulted in an inability of cells to progress through the cell-cycle. In an attempt to identify genes whose expression required yTAFII90, we performed subtractive hybridization on strains containing wild-type and temperature-sensitive alleles. Although this technique successfully identified genes differentially expressed in the two strains, it failed to identify genes whose expression required yTAFII90. These results indicate that TAFIIs are not the obligatory targets of activators, and that other factors must provide this role in vivo. Furthermore, that many of TAFIIs are required for cell-cycle progression.

La voie de réparation par excision de nucléotides (NER) répare les lésions qui distordent la double hélice d’ADN notamment ceux induits par l’irradiation UV. Le NER est subdivisé en deux sous-voies : GG-NER (Global Genome Repair) et TC-NER (Transcription-Coupled Repair). La sous-voie GG-NER enlève les dommages à l’ADN dans l’ensemble du génome. La sous-voie TC-NER répare les dommages sur le brin transcrit qui interfèrent avec la progression de l’ARN Pol II. Les défauts de la voie NER peuvent conduire à l’apparition de pathologies graves. Par exemple, des mutations dans le gène XPG, codant une 3’ endonucléase impliquée dans la voie NER, peuvent mener au xeroderma pigmentosum (XP) associé ou non au syndrome de Cockayne (CS).Récemment, le laboratoire a découvert un lien fonctionnel entre Rad2, homologue chez la levure Saccharomyces cerevisiae de la protéine XPG humaine, et le Médiateur (Eyboulet et al., 2013). Le Médiateur est un complexe multiprotéique nécessaire à la régulation de la transcription dépendante de l’ARN Pol II. Cette étude a suggéré que le Médiateur est impliqué dans la sous-voie TC-NER en facilitant le recrutement de Rad2 au niveau des régions transcrites.Mon projet de thèse visait à étudier les mécanismes moléculaires qui lient la transcription et la réparation de l’ADN. Plus précisément, d’investiguer le lien fonctionnel entre le Médiateur et la machinerie du NER chez S. cerevisiae.Lors du TC-NER, l’ARN Pol II est le premier facteur signalant le dommage à l’ADN. De plus, le Médiateur et Rad2 interagissent avec l’ARN Pol II. Pour déterminer le lien fonctionnel entre ces composants, nous avons utilisé des approches de génétique et génomique dans les mutants de TFIIH (kin28), de l’ARN Pol II (rpb9) and du Médiateur (med17). Nos résultats nous ont permis de proposer un modèle dans lequel Rad2 est recruté au niveau des régions régulatrices enrichies par le Médiateur, et Rad2 est ensuite transféré au niveau des régions transcrites de manière dépendante à l’ARN Pol II. De plus, ces résultats suggèrent que le rôle du Médiateur dans la transcription est fortement lié à son rôle dans la réparation de l’ADN.Ensuite, nous avons montré que le lien entre le Médiateur et la machinerie du NER peut être étendu à d’autres protéines du NER notamment en démontrant une interaction physique entre le Médiateur et Rad1/XPF, Rad10/ERCC1 ou Rad26/CSB, en l’absence des UV. Tout comme Rad2, nous avons démontré que Rad1 et Rad10 n’ont pas de rôle majeur dans la transcription. Pour approfondir le lien entre ces protéines du NER et le Médiateur, des expériences de ChIP-sequencing ont été réalisées. Nous avons observé que le Médiateur est présent au niveau de certaines régions qui sont aussi enrichies par ces protéines du NER. Après l’induction des dommages par UV, les interactions entre le Médiateur et la machinerie du NER reste inchangées par rapport aux conditions en l’absence des UV. De plus grâce à nos expériences de ChIP, nous avons observé un changement de la liaison à la chromatine des protéines du NER et du Médiateur après l’irradiation aux UV. Des expériences de ChIP-sequencing seront réalisées pour avoir une vue globale de ces changements.En conclusion, nous avons solidifié le lien fonctionnel entre Rad2, le Médiateur et l’ARN Pol II par rapport à la réparation couplée à la transcription. Nous avons aussi démontré que le Médiateur interagit avec d’autres protéines du NER (Rad1/XPF, Rad10/ERCC1 et Rad26/CSB) et colocalise avec eux sur certaines régions de la chromatine. En somme, notre projet place le Médiateur à l’interface de la transcription et de la réparation de l’ADN, deux processus essentiels dont les défauts peuvent mener à des pathologies graves. / Nucleotide excision repair (NER) is a well conserved pathway that removes helix-distorting DNA lesions such as those arising upon UV irradiation. Global genome repair subpathway (GG-NER) removes the DNA lesions in the genome overall, and transcription-coupled repair (TC-NER) removes the DNA lesions interfering with Pol II progression through actively-transcribed regions. Defects in the NER pathway may lead to severe human pathologies. For instance, mutations in human XPG gene, encoding a 3’ endonuclease essential for NER, give rise to xeroderma pigmentosum (XP) sometimes associated with Cockayne syndrome (CS). Recently, the laboratory discovered a functional link between Rad2/XPG and Mediator in Saccharomyces cerevisiae (Eyboulet et al., 2013). Mediator is a large multisubunit complex essential for transcription regulation. We suggest that Mediator is involved in TC-NER by facilitating Rad2 recruitment to transcribed genes.My PhD work aimed at addressing the molecular mechanisms of this link between transcription and DNA repair, especially by investigating the functional interplay between Mediator and the NER machinery in yeast Saccharomyces cerevisiae.RNA Pol II is the first complex of TC-NER that encounters the DNA damage. Moreover, both Mediator and Rad2/XPG interact with Pol II. However, a functional interplay between all these components related to TC-NER remained to be determined. Using genetic and genomic approaches, in particular ChIP-sequencing in TFIIH (kin28), RNA Pol II (rpb9) and Mediator (med17) mutants, our work led us to propose a model where Rad2 shuttles between Mediator on upstream activating sequence (UAS) and RNA Pol II on transcribed regions (Georges, Gopaul et al., under review). Our results also suggest that Mediator functions in transcription and DNA repair are closely related.Moreover, we showed that Mediator’s link to NER can be extended to other NER proteins. Indeed, we identified a physical interaction between Mediator and other NER proteins, including Rad1/XPF, Rad10/ERCC1 and Rad26/CSB in the absence of UV irradiation. Similarly to Rad2, we demonstrated that Rad1 and Rad10 do not have a major role in yeast transcription. To further study the functional link between Mediator and the NER machinery, we obtained the genomic distribution of different NER proteins by ChIP-sequencing. We found that some promoter regions are co-occupied by Mediator and these NER proteins, and that relationships between Mediator and these NER proteins are more complex than between Mediator and Rad2. We also investigated if physical interactions between Mediator and NER proteins are modified after UV, we did not observe any significant change. Furthermore, we observed that the chromatin binding profiles of NER proteins and Mediator are modified after UV-irradiation. ChIP-sequencing will be carried out to get a genome-wide view of their chromatin binding profiles.In conclusion, we have strengthened the link between Rad2/XPG, Mediator and RNA Pol II, providing mechanistic insights into functional interplay between these components related to transcription-coupled repair, and showed that the link between Mediator and the NER machinery can be extended to other proteins. Taken together, our results suggest a close relation between Mediator functions in transcription and in NER, two fundamental processes dysfunction of which leads to human diseases.

RNA polymerase II-mediated transcription of HIV-1 genes depends on positive transcription elongation factor b (P-TEFb), the complex of cyclin T1 and CDK9. Recent evidence suggests that regulation of transcription by P-TEFb involves chromatin binding and modifying factors. To determine how P-TEFb may connect chromatin remodeling to transcription, we investigated the relationship between P-TEFb and histone H1. We show that P-TEFb interacts with H1 and that H1 phosphorylation in cell culture correlates with P-TEFb activity. Importantly, P-TEFb also directs H1 phosphorylation during Tat transactivation and wild type HIV-1 infection. Our results also show that P-TEFb phosphorylates histone H1.1 at a specific C-terminal site. Expression of a mutant H1.1 that cannot be phosphorylated by P-TEFb disrupts Tat transactivation as well as transcription of the c-fos and hsp70 genes in HeLa cells. P-TEFb phosphorylation of H1 also plays a role in the expression of muscle differentiation marker genes in the skeletal myoblast cell line C2C12. Additionally, ChIP experiments demonstrate that H1 dissociates from the HIV-1 LTR in MAGI cells, stress-activated genes in HeLa cells, and muscle differentiation marker genes in C2C12 cells under active P-TEFb conditions. Our results overall suggest a new role for P-TEFb in both cellular and HIV-1 transcription through chromatin.